NCT03005418

Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma

CompletedPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2018-09-01Est. Completion: 2023-09-19

Enrollment target: 72 participants

Locations

Jacob Medical Center at UC San Diego, La Jolla, California, United States
Keck Hospital of University of Southern California (USC), Los Angeles, California, United States
Cedars-Sinai Medical Cener, Los Angeles, California, United States
UCI Medical Center, Orange, California, United States
University California, Davis, Sacramento, California, United States
University of California San Diego (UCSD) Medical Center, San Diego, California, United States
Ernest E Moore Shock Trauma Center at Denver Health, Denver, Colorado, United States
UF Health Jacksonville, Jacksonville, Florida, United States
Jackson South Medical Center, Miami, Florida, United States
Ryder Trauma Center, Miami, Florida, United States
Tampa General Hospital, Tampa, Florida, United States
Grady Memorial Hospital, Atlanta, Georgia, United States
R Adams Cowley Baltimore Shock Trauma, Baltimore, Maryland, United States
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States

Burn Injury

There is currently no standard treatment to prevent burn depth conversion in partial-thickness burns. Conversion into de…

Nashville, United StatesCompleted Jan 12, 2026

StrokeSarcopeniaKinesiophobia

The aim of this study is to evaluate the relationship between ultrasonography-measured quadriceps muscle thickness and t…

Istanbul, Turkey (Türkiye)Est. completion Aug 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.